Skip to content
easybpt
Browse topics

Respiratory and sleep medicine

Pulmonary vasculitides and pulmonary haemorrhage

How GPA, MPA, EGPA and anti-GBM disease affect the lung, recognising diffuse alveolar haemorrhage (rising DLCO, bloodier BAL aliquots), interpreting ANCA, induction with glucocorticoids plus rituximab or cyclophosphamide, and mepolizumab or benralizumab for EGPA.

Tier 2Condition

Written with AI assistance and fact-checked against the sources below. For exam study, not clinical decisions. How notes are made

3 questions9 flashcards

At a glance

  • Small-vessel vasculitis is the lung's main vasculitis: GPA, MPA, EGPA (the ANCA-associated vasculitides) and anti-GBM disease.
  • The respiratory emergency is diffuse alveolar haemorrhage (DAH). Think of it in anyone with new bilateral infiltrates and a falling haemoglobin, with or without haemoptysis.
  • Pulmonary-renal syndrome (lung haemorrhage plus glomerulonephritis) is ANCA vasculitis or anti-GBM until proven otherwise. Send ANCA and anti-GBM the same day.

Loading the rest of the note…

Finished reading?

Test yourself on it:3 questions9 flashcards

Sources

Last updated
14 November 2026
What changed
  • 14 November 2026 Turnstile bot check on sign-in and signed-out feedback

Send feedback

Type of feedback

The page you're on and your device type are attached automatically.